Skip to main content
Fig. 6 | Journal of Translational Medicine

Fig. 6

From: Tumor aggression-defense index–a novel indicator to predicts recurrence and survival in stage II-III colorectal cancer

Fig. 6

Relationship between TADI and clinical outcome among stage II colorectal cancer patients treated with ACT. A The Kaplan–Meier curve was used to analyze the TTR of stage II pMMR CRC based on their TADI status and receipt of ACT. B The Kaplan–Meier curve was used to analyze the OS of stage II pMMR CRC based on their TADI status and receipt of ACT. C Forest plot for time to recurrence and overall survival according to ACT (yes or no) among patients with stage II pMMR CRC. TADI, Tumor Aggression-Defense Index; ACT, adjuvant chemotherapy treatments; TTR, time to recurrence; OS, overall survival

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us